Stock Events

Stock Events

Sihuan Pharmaceutical Group 

€0.15
6
-€0-2.68% Thursday 13:17

Statistics

Day High
0.15
Day Low
0.15
52W High
0.2
52W Low
0.06
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
1.65%
Dividend
0

Upcoming

30
JUN
Dividend Ex
Decreased
 
16
JUL
Dividend Payment
Decreased
 
28
SEP
Dividend Ex
Estimated
 
9
OCT
Dividend Payment
Estimated
 
30
JUN 27
Dividend Ex
Estimated
 

Dividends

1.65%Dividend Yield
Oct 25
€0
Oct 24
€0
Jun 23
€0
Oct 22
€0
Oct 22
€0
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

31MarExpected
Q4 2025
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TEL1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap116.3B
GlaxoSmithKline is a global healthcare company that competes in various pharmaceutical sectors, including areas where Sihuan Pharmaceutical operates.
Pfizer
PFE
Mkt Cap153.13B
Pfizer is a large pharmaceutical company with a broad range of products that compete in the same market segments as Sihuan Pharmaceutical.
Novartis
NVS
Mkt Cap297.35B
Novartis is a global healthcare company that offers products in multiple areas, including those where Sihuan Pharmaceutical is active, making it a direct competitor.
Merck
MRK
Mkt Cap300.2B
Merck & Co., Inc. is a leading pharmaceutical company with a diverse product portfolio that competes with Sihuan Pharmaceutical's offerings.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson is a healthcare giant that operates in various pharmaceutical niches, competing with Sihuan Pharmaceutical across several product lines.
Sanofi
SNY
Mkt Cap113.88B
Sanofi is a global pharmaceutical company with a wide range of products that compete with Sihuan Pharmaceutical, especially in the areas of cardiovascular and metabolic diseases.
Abbvie
ABBV
Mkt Cap367.8B
AbbVie is a research-based biopharmaceutical company with a strong presence in areas like immunology and oncology, competing with Sihuan Pharmaceutical.
Astrazeneca
AZN
Mkt Cap316.3B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with products that compete in the same therapeutic areas as Sihuan Pharmaceutical.
Bristol-Myers Squibb
BMY
Mkt Cap119.69B
Bristol Myers Squibb is a global biopharmaceutical company with a focus on discovering, developing, and delivering innovative medicines that compete with Sihuan Pharmaceutical.
Roche
RHHBY
Mkt Cap322.3B
Roche Holding AG is a healthcare company that engages in the research and development of pharmaceuticals and diagnostics, competing with Sihuan Pharmaceutical in several key areas.

About

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthetics comprehensive solutions. It also provides drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. In addition, the company involved in the provision of research and development, and industrialization of innovative medicine; construction for medical project; provision of general hospital services and hospital management services; and property investment business. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.
Show more...
CEO
Dr. Fengsheng Che
Employees
2843
Country
Bermuda
ISIN
BMG8162K1137

Listings

STU
DE
TEL1.STU
OTC Link
US
SHPHY
F
DE
TEL1.F
MU
DE
TEL1.MU

0 Comments

Share your thoughts

FAQ

What is Sihuan Pharmaceutical Group stock price today?▼
The current price of TEL1.STU is €0.15 EUR — it has decreased by -2.68% in the past 24 hours. Watch Sihuan Pharmaceutical Group stock price performance more closely on the chart.
What is Sihuan Pharmaceutical Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sihuan Pharmaceutical Group stocks are traded under the ticker TEL1.STU.
Is Sihuan Pharmaceutical Group stock price growing?▼
TEL1.STU stock has fallen by -1.36% compared to the previous week, the month change is a +0.69% rise, over the last year Sihuan Pharmaceutical Group has showed a +135.77% increase.
When is the next Sihuan Pharmaceutical Group earnings date?▼
Sihuan Pharmaceutical Group is going to release the next earnings report on September 01, 2026.
Does Sihuan Pharmaceutical Group pay dividends?▼
Yes, TEL1.STU dividends are paid semi-annual. The last dividend per share was 0 EUR. As of today, Dividend Yield (FWD)% is 1.65%.
How many employees does Sihuan Pharmaceutical Group have?▼
As of April 19, 2026, the company has 2,843 employees.
In which sector is Sihuan Pharmaceutical Group located?▼
Sihuan Pharmaceutical Group operates in the Health & Wellness sector.
When did Sihuan Pharmaceutical Group complete a stock split?▼
Sihuan Pharmaceutical Group has not had any recent stock splits.
Where is Sihuan Pharmaceutical Group headquartered?▼
Sihuan Pharmaceutical Group is headquartered in Wan Chai, Bermuda.